As part of the patient’s treatment and health care prevention, a list of pharmacological and non-pharmacological nursing intervention was discussed in this study. Aside from identifying the most current U.S. health care policy and the financial condition of the patient, this study tackled the importance of health ethics in the practice of nursing.
Metabolic syndrome is also known as – dysmetabolic syndrome, insulin resistance syndrome, deadly quartlet, obesity syndrome, syndrome X, and Reaven’s syndrome (Shaw & Zimmet, 2003). Metabolic syndrome is referring to a combination of metabolic abnormalities that is often characterized by abdominal obesity, the inability to process glucose causing insulin resistance or a significant increase in the blood glucose level, atherogenic dyslipidemia (blood fat disorders including high levels of triglycerides, high LDL cholesterol causing plaque build-ups within the artery walls, and low HDL cholesterol), and hypertension (American Heart Association, 2010; Shaw & Zimmet, 2003).
Because of the presence of four deadly diseases (obesity, insulin resistance, dyslipidemia, and hypertension), individuals who has been diagnosed with metabolic syndrome are at risk of developing cardiovascular diseases (CVDs) and type II diabetes. Because of the presence of plaque build-ups within the artery walls, individuals with metabolic syndrome are also likely to experience either stroke or peripheral vascular disease (American Heart Association, 2010).
Considering the case of the Japanese patient presented below, this paper will first discuss the different definition of metabolic syndrome as provided by the World Health Organization (WHO), the 1999 EGIR, and the 2001 ATP III followed by discussing the epidemiology and demographics as well as the etiology behind metabolic syndrome. In relation to the case of the patient, this study will discuss the